Neglected diseases

The neglected diseases are a group of tropical infections which are especially endemic in low-income populations in developing regions of Africa, Asia, and the Americas. Different organizations define the set of diseases differently. In sub-Saharan Africa, the impact of these diseases as a group is comparable to malaria and tuberculosis.[1] Some of these diseases have known preventive measures or acute medical treatments which are available in the developed world but which are not universally available in poorer areas. In some cases, the treatments are relatively inexpensive. For example, the treatment for schistosomiasis is USD $0.20 per child per year.[2] Nevertheless, control of neglected diseases is estimated to require funding of between US$2 billion to US$3 billion over the next five to seven years.[3]

These diseases are contrasted with the big three diseases (HIV/AIDS, tuberculosis, and malaria), which generally receive greater treatment and research funding. The neglected diseases can also make HIV/AIDS and tuberculosis more deadly.[4] However, some pharmaceutical companies have committed to donating all the drug therapies required and mass drug administration has been successfully accomplished in several countries.[5]

Contents

List of diseases

Neglected tropical diseases include in order of decreasing prevalence:[6]

The World Health Organization (WHO) list of neglected tropical diseases also adds the following additional diseases: Cysticercosis, Dengue/dengue haemorrhagic fever, Echinococcosis, Fascioliasis, Rabies , Yaws; and includes two other 'neglected' conditions’: Podoconiosis (also known as elephantiasis) and Snakebite.[7]

Trypanosomal parasites

Worm (helminth) parasites

Soil-transmitted helminthiases

Bacterial infections

Viral infections

Incentives for research and development

The U.S. Food and Drug Administration priority review voucher is an incentive for companies to invest in new drugs and vaccines for tropical diseases. A provision of the Food and Drug Administration Amendments Act (HR 3580) awards a transferable “priority review voucher” to any company that obtains approval for a treatment for one of the listed diseases. The voucher can later be used to accelerate review of an unrelated drug. This program is for all tropical diseases and includes medicines for malaria and tuberculosis. The first voucher given was for Coartem, a malaria treatment.[12] It does not use or define the term "neglected" though most of the diseases listed are often included on lists of neglected diseases.

The prize was proposed by Duke University faculty Henry Grabowski, Jeffrey Moe, and David Ridley in their 2006 Health Affairs paper: "Developing Drugs for Developing Countries."[13] In 2007 United States Senators Sam Brownback (R-KS) and Sherrod Brown (D-OH) sponsored an amendment to the Food and Drug Administration Amendments Act of 2007. President George W. Bush signed the bill in September 2007.

Biotechnology companies in the developing world have targeted neglected tropical diseases due to need to improve global health.[14]

Anacor Pharmaceuticals, located in Palo Alto, California, is a biopharmaceutical company with a unique chemistry platform using the element boron in its therapeutic compounds. Its boron chemistry platform appears to be well suited for the treatment of neglected diseases therefore Anacor has partnered with several not-for-profit organizations to discover therapies for these diseases. Anacor currently has partnerships with Drugs for Neglected Diseases Initiative to develop new therapeutics for African Sleeping Sickness, Visceral Leishmaniasis, and Chagas Disease; Medicines for Malaria Venture to develop new therapeutics for the treatment of malaria; the TB Alliance to explore therapeutics for tuberculosis; UCSF's Sandler Center to identify a drug candidate for River Blindness; and the Institute for OneWorld Health to identify antibacterial compounds to treat shigellosis, or bloody diarrhea.

See also

References

  1. ^ Hotez PJ, Kamath A (2009). Cappello, Michael. ed. "Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden". PLoS Negl Trop Dis 3 (8): e412. doi:10.1371/journal.pntd.0000412. PMC 2727001. PMID 19707588. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2727001. 
  2. ^ "Making the Case to Fight Schistosomiasis". National Public Radio. http://www.npr.org/templates/story/story.php?storyId=7806977. Retrieved 2008-12-01. 
  3. ^ P.J.Hotez. "How To Cure 1 Billion People? -- Defeat Neglected Tropical diseases". Scientific American. http://www.scientificamerican.com/article.cfm?id=a-plan-to-defeat-neglected-tropical-diseases. Retrieved 1 January 2010. 
  4. ^ Mike Shanahan (31 January 2006). "Beat neglected diseases to fight HIV, TB and malaria". SciDev.Net. http://www.scidev.net/News/index.cfm?fuseaction=readNews&itemid=2629&language=1. 
  5. ^ Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA (October 2007). "Oral drug therapy for multiple neglected tropical diseases: a systematic review". JAMA 298 (16): 1911–24. doi:10.1001/jama.298.16.1911. PMID 17954542. 
  6. ^ World Health Organization, apud Reddy M et al.:"Key Features of 13 Neglected Tropical Diseases Listed by Prevalence - 2007". The Journal of the American Medical Association. http://jama.ama-assn.org/content/298/16/1911/T1.large.jpg. Retrieved 2011-09-17. 
  7. ^ World Health Organisation: Diseases covered by NTD Department. http://www.who.int/neglected_diseases/diseases/en/
  8. ^ "Human African Trypanosomiasis: number of new cases falls to historical low in 50 years". http://www.who.int/neglected_diseases/integrated_media/integrated_media_hat_june_2010/en/index.html 
  9. ^ "Schistosomiasis Fact Sheet". CDC, Division of Parasitic Diseases. http://www.cdc.gov/ncidod/dpd/parasites/schistosomiasis/factsht_schistosomiasis.htm. Retrieved 2008-12-03. 
  10. ^ Mohammed KA, Hail HJ, Gabrielli AF. et al. (2008). Utzinger, Juerg. ed. "Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study". PLoS Negl Trop Dis 2 (1): e171. doi:10.1371/journal.pntd.0000171. PMC 2217668. PMID 18235853. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2217668. 
  11. ^ World Health Organisation. Weekly Epidemiology Record 85, no 19, p. 166: Dracunculiasis eradication - global surveillance summary, 2009. World Health Organization. http://www.who.int/entity/wer/2010/wer8519.pdf. Retrieved 2010-05-14 
  12. ^ "FDA Approves Coartem Tablets to Treat Malaria". USFDA. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149559.htm. Retrieved 11 December 2009. 
  13. ^ Ridley DB, Grabowski HG, Moe JL (2006). "Developing drugs for developing countries". Health Aff (Millwood) 25 (2): 313–24. doi:10.1377/hlthaff.25.2.313. PMID 16522573. 
  14. ^ Frew SE, Liu VY, Singer PA (2009). "A business plan to help the 'global South' in its fight against neglected diseases". Health Aff (Millwood) 28 (6): 1760–73. doi:10.1377/hlthaff.28.6.1760. PMID 19887417. http://siteresources.worldbank.org/EDUCATION/Resources/278200-1099079877269/547664-1099079975330/Peter_Singer_Neglected_Tropical_Diseases.pdf. 

External links